For older adults residing in studio apartments (SAs), living with physical functional difficulty, chronic conditions, having low social support, low self-perceived mental health, poor life satisfaction, low physical activity and being widowed increase the likelihood of developing depression, suggests a Singapore study.
The Malaysian Psychiatric Association (MPA), Malaysian Mental Health Association (MMHA) and Pfizer Malaysia jointly launched a new mental health handbook in December 2019 to highlight the signs and symptoms of mental health issues and encourage Malaysians to see a doctor early if they experience any signs or symptoms.
While the SSRI fluoxetine appeared to improve obsessive-compulsive behaviours at 16 weeks compared with placebo in children and adolescents with autism spectrum disorders (ASD) in the initial analysis, the difference between groups became nonsignificant after correcting for potential confounding factors and imbalances in baseline characteristics, reveals the FAB* study.
Concurrent depressive symptoms were more commonly reported in 16-year-old oral contraceptive pill (OCP) users compared with OCP non-users, according to a recent analysis of data from a prospective Dutch population survey.
New drug applications approved by US FDA as of 16 - 31 December 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
In this issue of MIMS PsychiatrySupplement, we bring you clinical updates related to managing depression and optimizing functional recovery in patients with depression, as well as a symposium highlight of the Lundbeck Malaysia Neuroscience Symposium.